1,2,5,8-tetrahydroxy anthraquinone has been researched along with epigallocatechin gallate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briggs, JM; Bushman, FD; Carlson, HA; Jorgensen, WL; Lins, RD; Masukawa, KM; McCammon, JA; Rubins, K | 1 |
| Cale, JM; Emal, CD; Lawrence, DA; Li, SH; North, PR; Puscau, MM; Sanders, KL; Su, EJ; Warnock, M | 1 |
| Bulic, B; Mandelkow, E; Pickhardt, M | 1 |
| Dunckley, T; Gokhale, V; Hulme, C; Medda, F; Smith, B | 1 |
2 review(s) available for 1,2,5,8-tetrahydroxy anthraquinone and epigallocatechin gallate
| Article | Year |
|---|---|
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Humans; Hydrogen Bonding; Models, Molecular; Protein Binding; Protein Conformation; Structure-Activity Relationship; tau Proteins | 2013 |
Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?
Topics: Alzheimer Disease; Animals; Anthraquinones; Biomedical Research; Carbolines; Catechin; Chromosomes, Human, Pair 21; Coumarins; Down Syndrome; Drug Design; Dyrk Kinases; Humans; Mice; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; tau Proteins | 2012 |
2 other study(ies) available for 1,2,5,8-tetrahydroxy anthraquinone and epigallocatechin gallate
| Article | Year |
|---|---|
Developing a dynamic pharmacophore model for HIV-1 integrase.
Topics: Computer Simulation; Drug Evaluation, Preclinical; HIV Integrase; HIV Integrase Inhibitors; Models, Chemical; Models, Molecular; Protein Conformation; Structure-Activity Relationship | 2000 |
Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1.
Topics: Animals; Drug Design; Electrophoresis, Polyacrylamide Gel; Flavonoids; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenols; Plasminogen Activator Inhibitor 1; Polyphenols; Protease Inhibitors; Recombinant Proteins; Serpin E2; Serpins; Surface Plasmon Resonance; Vitronectin | 2010 |